Animal Model Market Introduction

Animal models refer to non-human animals that are used in scientific research for the purpose of studying diseases, developing new drugs, and understanding biological processes. Animal models have played a crucial role in advancing our understanding of human physiology and pathology, and have contributed to the development of many important medical treatments.Animal models can be used to study a wide range of diseases, including cancer, diabetes, cardiovascular diseases, and neurological disorders, among others. They are also used in the development of new drugs and therapies, as well as in toxicity testing.Animal models are used in many different types of research, including basic research, applied research, and preclinical research. Basic research seeks to understand fundamental biological processes, while applied research focuses on using that knowledge to develop new technologies and treatments. Preclinical research involves testing new treatments and therapies in animals before they are tested in humans.The use of animal models in research is subject to ethical considerations, and guidelines and regulations have been established to ensure that animal research is conducted in a humane and ethical manner. The use of animal models in research is also subject to regulatory approval, and researchers must obtain approval from the appropriate regulatory bodies before conducting animal research.

Animal Model Market Size

The global market for animal models was valued at $1.7 billion in 2020 and is projected to reach $2.9 billion by 2025, growing at a CAGR of 11.1% during the forecast period. The mice segment is expected to dominate the market, with the largest share attributed to the increasing use of mice in research for oncology, immunology, and neuroscience. The Asia Pacific region is expected to witness the highest growth in the market due to the rising investment in research and development activities and the increasing focus on personalized medicine. Overall, the animal model market is expected to continue to grow due to the increasing demand for new treatments and therapies and the continued importance of animal models in drug development and other areas of research.

Animal Model Market Share

Some of the key players in the global animal model market include Charles River Laboratories International Inc., Envigo, The Jackson Laboratory, Taconic Biosciences, and Janvier Labs. These companies have a significant share of the market and offer a wide range of animal models and related services. However, there are also many smaller companies and research institutions that play a role in the animal model market, particularly in the development of novel animal models and in specialized areas of research. The market share of these players varies depending on the specific animal model and application, but overall, the key players dominate the market due to their established infrastructure, expertise, and global reach.

Animal Model Market Trends

The animal model market is witnessing several trends that are shaping the industry. Some of the key trends in the animal model market include:

Increasing demand for genetically modified animal models: There is a growing demand for genetically modified animal models as they provide researchers with more precise and targeted models for their research. The development of CRISPR gene editing technology has made it easier and more efficient to create genetically modified animal models, leading to an increase in their use in research.Growing focus on personalized medicine: There is a growing focus on personalized medicine, which requires more specialized animal models to mimic specific human diseases and conditions. This has led to an increase in the development of humanized animal models, which have human genes or tissues implanted into animal models to create more accurate representations of human disease.Increasing use of non-mammalian animal models: While mammalian animal models such as mice and rats remain the most commonly used animal models, there is growing interest in using non-mammalian animal models such as zebrafish, fruit flies, and nematodes. These models offer unique advantages such as lower cost, faster generation time, and the ability to study complex biological processes.Growing demand for contract research services: There is an increasing trend towards outsourcing animal model research to contract research organizations (CROs) due to their specialized expertise and infrastructure. This trend is expected to continue as more companies look to streamline their research and development activities.Growing focus on animal welfare: There is a growing focus on animal welfare in the animal model industry, with many companies implementing more ethical and humane practices in their research activities. This includes the development of more sophisticated animal housing and care facilities, the use of alternative testing methods, and the reduction of animal use wherever possible.

Animal Model Market Driving Factors

The animal model market is driven by several factors, including:

Increased funding for biomedical research: Governments and private organizations are investing more money in biomedical research, which is driving the demand for animal models. Animal models are an essential tool for testing new drugs and therapies, and for gaining a better understanding of complex biological processes.Growing prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is increasing worldwide. This is driving the demand for animal models that can mimic these diseases and be used to develop new treatments.Advancements in gene editing technologies: Recent advancements in gene editing technologies such as CRISPR-Cas9 have made it easier and more efficient to create genetically modified animal models. This has led to an increase in their use in research, particularly in the development of personalized medicine.Increased demand for preclinical testing: The pharmaceutical and biotechnology industries are increasingly relying on animal models for preclinical testing of new drugs and therapies. Animal models provide a more accurate representation of human physiology than in vitro testing, which is driving the demand for these models.Technological advancements in animal model development: Advances in animal model development technologies such as transgenic and knockout technologies have allowed for the creation of more sophisticated and precise animal models. This has expanded the range of applications for animal models, leading to increased demand.

Animal Model Market Regional Analysis

The animal model market is a global market that is segmented into various regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.North America dominates the animal model market due to the presence of a large number of biopharmaceutical companies and academic research institutes, as well as the availability of advanced research infrastructure. The United States is the largest market in the region, accounting for the majority of the market share.Europe is the second-largest market for animal models, with a strong presence of academic and research institutions, and a high demand for animal models for drug discovery and research. The United Kingdom, Germany, and France are the major markets in the region.The Asia-Pacific region is expected to witness the fastest growth in the animal model market due to the increasing focus on drug discovery and development, rising investment in research and development, and the availability of low-cost animal models. China, India, and Japan are the major markets in the region.Latin America and the Middle East and Africa are also expected to witness significant growth in the animal model market, driven by increasing investments in biomedical research and the rising prevalence of chronic diseases. However, the market in these regions is relatively smaller compared to other regions.

Animal Model Market Forecasts 2030 

The global animal model market is expected to experience significant growth from 2021 to 2030. Factors such as the increasing demand for personalized medicine, rising investments in drug discovery and development, and the growing prevalence of chronic diseases are expected to drive the growth of the market.The animal model market is expected to grow at a CAGR of around 6% during the forecast period, and it is expected to reach a market value of over $10 billion by 2030.In terms of species, mice are expected to remain the most widely used animal model in biomedical research due to their genetic similarity to humans, ease of maintenance, and cost-effectiveness. The demand for transgenic and knockout mice is expected to increase significantly in the coming years.In terms of application, the drug discovery and development segment is expected to hold the largest market share, driven by the increasing need for novel and effective drugs for the treatment of various diseases. Other applications such as toxicology testing, basic research, and preclinical research are also expected to witness significant growth during the forecast period.Geographically, the Asia-Pacific region is expected to witness the fastest growth in the animal model market due to the increasing investment in research and development, the availability of low-cost animal models, and the rising prevalence of chronic diseases. North America is expected to remain the largest market for animal models, driven by the presence of a large number of biopharmaceutical companies and academic research institutes.

Animal Model Market Key Industry Players

Some of the key industry players in the global animal model market include:

Charles River Laboratories International, Inc.

The Jackson Laboratory

Envigo

Taconic Biosciences, Inc.

Laboratory Corporation of America Holdings (Covance)

Trans Genic Inc.

JANVIER LABS

Genoway S.A.

Pharmaron Beijing Co., Ltd.

Crown Bioscience Inc.

These companies are actively involved in the development and production of animal models for research purposes, as well as in providing related services such as breeding, health monitoring, and technical support. They are also investing in research and development activities to improve the quality and relevance of their animal models and to expand their product portfolios. These companies are also engaging in strategic collaborations and partnerships with academic and research institutions, pharmaceutical and biotech companies, and government agencies to enhance their research capabilities and to address the needs of the scientific community.